Shanxi C&Y Pharmaceutical Group Co Ltd
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, comme… Read more
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.092x
Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a cash flow conversion efficiency ratio of 0.092x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.93 Million) by net assets (CN¥577.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanxi C&Y Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanxi C&Y Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
North American Construction Group Ltd
NYSE:NOA
|
0.271x |
|
Kido Group Corp
VN:KDC
|
0.061x |
|
PT Lippo Karawaci Tbk
PINK:PTLKF
|
-0.009x |
|
Virgin Australia Holdings Ltd
AU:VGN
|
-0.244x |
|
Sanyo Chemical Industries Ltd
F:XSI
|
0.036x |
|
Jasmine Telecom Systems Public Company Limited
BK:JTS
|
0.120x |
|
Zhejiang Jianfeng Group Co Ltd
SHG:600668
|
0.022x |
|
Central Reinsurance Corp
TW:2851
|
0.050x |
Annual Cash Flow Conversion Efficiency for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥598.18 Million | CN¥70.94 Million | 0.119x | +144.13% |
| 2023-12-31 | CN¥778.43 Million | CN¥37.81 Million | 0.049x | -52.66% |
| 2022-12-31 | CN¥729.68 Million | CN¥74.88 Million | 0.103x | -21.17% |
| 2021-12-31 | CN¥744.58 Million | CN¥96.92 Million | 0.130x | +644.07% |
| 2020-12-31 | CN¥872.61 Million | CN¥-20.88 Million | -0.024x | -132.04% |
| 2019-12-31 | CN¥932.60 Million | CN¥69.63 Million | 0.075x | +80.88% |
| 2018-12-31 | CN¥931.24 Million | CN¥38.44 Million | 0.041x | -0.04% |
| 2017-12-31 | CN¥971.17 Million | CN¥40.10 Million | 0.041x | -5.33% |
| 2016-12-31 | CN¥954.85 Million | CN¥41.65 Million | 0.044x | +146.44% |
| 2015-12-31 | CN¥872.50 Million | CN¥15.44 Million | 0.018x | -82.27% |
| 2014-12-31 | CN¥823.16 Million | CN¥82.19 Million | 0.100x | -4.94% |
| 2013-12-31 | CN¥767.16 Million | CN¥80.58 Million | 0.105x | +95.14% |
| 2012-12-31 | CN¥651.17 Million | CN¥35.05 Million | 0.054x | +558.60% |
| 2011-12-31 | CN¥581.17 Million | CN¥4.75 Million | 0.008x | -97.65% |
| 2010-12-31 | CN¥149.59 Million | CN¥52.03 Million | 0.348x | -61.24% |
| 2009-12-31 | CN¥117.60 Million | CN¥105.55 Million | 0.898x | +344.54% |
| 2008-12-31 | CN¥106.70 Million | CN¥-39.16 Million | -0.367x | -- |